Compass Therapeutics, Inc.
CMPXNASDAQHealthcareBiotechnology
Previous close
$2.40
+$0.04 · +1.69%
CMPX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
33
Expensive
Momentum
34
Weakening
Sentiment
67
Bullish
Risk resilience
39
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteCompass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Thomas J. Schuetz
- Listed since
- Apr 5, 2021
- Employees
- 39
Market position
Day range
Current $2.40
52-week range
Current $2.40
- Open
- $2.365
- Previous close
- $2.36
- Volume
- 2.03M
- 0.27× average
- Average volume
- 7.58M
- Average daily volume
- Market cap
- 432.21M USD
- Beta
- 0.82
- Market reference 1
- 50-day average
- $2.1395
- +12.18% above average
- 200-day average
- $4.0764
- -41.12% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 826.01M USD
- P/E (TTM)
- -5.78×
- P/B (TTM)
- 2.7×
- P/S (TTM)
- 0×
- EV / EBITDA
- -12.7×
- Earnings yield
- -7.85%
- Free cash flow yield
- -5.81%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -33.79%
- Return on assets
- -30.28%
- Return on invested capital
- -35.25%
Financial health
- Debt / equity
- 0.06×
- Current ratio
- 15.02×
Earnings
- EPS beat rate
- 36%
- 4 beats, 4 misses, 3 met estimates
- Average EPS surprise
- +4.55%
- 11 comparable reports
- Latest EPS result
- -0.13
- Estimate -0.11 · Miss by 17.47%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
16 ratingsCMPX news
CMPX peers
ETFs holding CMPX
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P Biotech ETFXBI16.94M0.15%11.39B USD0.35%$165.73+1.44%
iShares Russell 2000 ETFIWM8.04M0.01%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI8M0.00%2.3T USD0.03%$378.24+0.44%
Fidelity Enhanced Small Cap ETFFESM3.63M0.06%6.03B USD0.28%$47.94+0.80%
Vanguard Extended Market ETFVXF3.43M0.00%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN2.84M0.02%14.66B USD0.24%$224.81+0.45%
Vanguard Russell 2000 ETFVTWO1.4M0.01%17.4B USD0.06%$121.25+0.74%
iShares Micro-Cap ETFIWC1.07M0.07%1.53B USD0.60%$198.39+1.10%State Street SPDR S&P Biotech ETFXBI- Market value
- 16.94M
- Weight
- 0.15%
- AUM
- 11.39B USD
- Expense ratio
- 0.35%
- Price / 1D
- $165.73+1.44%
iShares Russell 2000 ETFIWM- Market value
- 8.04M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 8M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Fidelity Enhanced Small Cap ETFFESM- Market value
- 3.63M
- Weight
- 0.06%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94+0.80%
Vanguard Extended Market ETFVXF- Market value
- 3.43M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 2.84M
- Weight
- 0.02%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.4M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
iShares Micro-Cap ETFIWC- Market value
- 1.07M
- Weight
- 0.07%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Continue in GoAI
Research CMPXresearch.disclaimer